SIRT3 and mitochondrial disease: In summary, pterostilbene in combination with mitochondrial cofactors treatment activates SIRT3 and UPRmt as compensatory mechanisms as well as enhance sirtuins’ levels and mitochondrial activity in several cell models of mitochondrial diseases.